project id: TCGA-THCA; case submitter id: TCGA-EL-A3GY; source center: 23; state: released; a260 a280 ratio: 1.75; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.7; age at index: 40; days to birth: -14814; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1964; age at diagnosis: 14814; ajcc pathologic m: M1; ajcc pathologic n: N1; ajcc pathologic stage: Stage II; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3076.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2698; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-EL-A3GY-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;